DNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolones

被引：50
|
作者：
Bébéar, CM [1 ]
Renaudin, H [1 ]
Charron, A [1 ]
Clerc, M [1 ]
Pereyre, S [1 ]
Bébéar, C [1 ]
机构：
[1] Univ Bordeaux 2, Bacteriol Lab, F-33076 Bordeaux, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2003年 / 47卷 / 10期
关键词：
D O I：
10.1128/AAC.47.10.3323-3325.2003
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Twelve clinical isolates of Ureaplasma spp. and one isolate of Mycoplasma hominis were examined for resistance to fluoroquinolones. Previously described mutations at positions 83 and 95 in GyrA (Escherichia coli numbering) and positions 80 and 87 in ParC were found. Unusual alterations were described at positions ParC 123 and 134.
引用
收藏
页码：3323 / 3325
页数：3
相关论文
共 50 条
  • [31] Prevalence of Mycoplasma hominis and Ureaplasma spp. in Routine Gynecological Care in Sao Paulo City, Brazil
    Milanezi, Fernanda
    Falconi, Ariane
    Schnabel, Beatriz
    Ricardi, Luana R.
    Monfredini, Priscilla M.
    Ziliotto, Alline T.
    Lopes, Vanessa F.
    Machado, Silvana A.
    Oliveira, Marinelia J.
    Centrone, Cristiane C.
    Nakano, Viviane
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2016, 11 (03):
  • [32] Quinolone resistance mutations in topoisomerase IV: Relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus
    Ng, EY
    Trucksis, M
    Hooper, DC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) : 1881 - 1888
  • [33] Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins
    Fernández-Moreira, E
    Balas, D
    González, I
    de la Campa, AG
    MICROBIAL DRUG RESISTANCE, 2000, 6 (04) : 259 - 267
  • [34] DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Staphylococcus haemolyticus
    Yonezawa, M
    Takahata, M
    BanzawaFutakuchi, N
    Matsubara, N
    Watanabe, Y
    Narita, H
    Matsunaga, T
    Igarashi, H
    Kawahara, M
    Onodera, S
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (04) : 1065 - 1066
  • [35] DNA GYRASE MUTATIONS IN QUINOLONE-RESISTANT CLINICAL ISOLATES OF NEISSERIA-GONORRHOEAE
    DEGUCHI, T
    YASUDA, M
    ASANO, M
    TADA, K
    IWATA, H
    KOMEDA, H
    EZAKI, T
    SAITO, I
    KAWADA, Y
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (02) : 561 - 563
  • [36] Mycoplasma and Ureaplasma spp. in clinical practice of ano-genital infections
    Fernandez-Huerta, Miguel
    Pich, Oscar Q.
    Espasa, Mateu
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2022, 35 (03) : 301 - 303
  • [37] Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China
    Hu, Li-Fen
    Li, Jia-Bin
    Ye, Ying
    Li, Xu
    JOURNAL OF MICROBIOLOGY, 2007, 45 (02) : 168 - 170
  • [38] DNA gyrase and topoisomerase IV mutations associated with fluoroquinolone resistance in Proteus mirabilis
    Weigel, LM
    Anderson, GJ
    Tenover, FC
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (08) : 2582 - 2587
  • [39] The Genome Structure of Ciprofloxacin-Resistant Mycoplasma Hominis Clinical Isolates
    Kolesnikova, E. A.
    Brusnigina, N. F.
    Makhova, M. A.
    Alekseeva, A. E.
    ACTA NATURAE, 2020, 12 (01): : 56 - 62
  • [40] DNA GYRASE GYRA MUTATIONS IN QUINOLONE-RESISTANT CLINICAL ISOLATES OF PSEUDOMONAS-AERUGINOSA
    YONEZAWA, M
    TAKAHATA, M
    MATSUBARA, N
    WATANABE, Y
    NARITA, H
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (09) : 1970 - 1972
12345